echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Osaikang Pharmaceutical's dexrazoxane for injection has been approved

    Osaikang Pharmaceutical's dexrazoxane for injection has been approved

    • Last Update: 2021-03-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 17, the official website of the State Administration of Food and Drug Administration showed that Jiangsu Aosaikang Pharmaceutical's dexrazoxane for injection was approved for listing in imitation 3 categories, and it was deemed to have been reviewed.


    Data show that dexrazoxane is an anthracycline cardiotoxicity protective agent.


    According to data from Menet.


    Source: MED2.


    At present, the supplementary application for consistency evaluation of dexrazoxane for injection previously approved by Jiangsu Aosaikang Pharmaceutical is under review and approval; Shanghai Kaimao Biomedicine | Shanghai Longsha Fosun Pharmaceutical, Nanjing Zhengda Tianqing Pharmaceutical are all using generic 3 Submission of a listing application for this category is under review and approval, and after approval, it is deemed to have been reviewed.


    Source: official website of the State Food and Drug Administration, Mi Nei.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.